Sun Pharma announces promising data for new indication on Ilumya drug

Sun Pharma announces promising data for new indication on Ilumya drug The interim analysis revealed that over 71 percent of patients treated with Ilumya experienced a 20 percent improvement in joint and skin symptoms, meeting the primary endpoint of the study, Sun Pharma said in a statement.

No comments:

Post a Comment